<p>南卡罗来纳州北查尔斯顿 --（商业资讯）--Ingevity Corporation（纽约证券交易所代码：NGVT）今天宣布了关键的高管领导变动，以完成其战略投资组合审查并为公司的未来做好准备。</p>
<p><strong>首席财务官过渡</strong></p>
<p>Mary Dean Hall，执行副总裁兼首席财务官（CFO），将于 2026 年 5 月 1 日起从当前职位过渡，并在接下来的一年内继续以顾问身份支持公司。自 2021 年以来，Hall 一直担任 CFO，在加强 Ingevity 的财务基础、提升运营纪律和支持战略增长计划方面发挥了关键作用。在她的财务领导下，公司实现了显著的利润率扩张，改善了资本结构，并交出了强劲的自由现金流表现。</p>
<p>“Mary 一直是我们财务战略的可信顾问和推动力，” 首席执行官 Dave Li 表示。“她深厚的专业知识和稳定的指导对 Ingevity 的长期成功至关重要。我们感谢她的领导，并很高兴她在这一过渡期间继续支持公司。”</p>
<p>公司已任命 Phillip J. Platt，现任高级副总裁、财务和首席会计官，作为 Hall 的继任者，并成为执行领导团队的一员，任职将于 2026 年 5 月 1 日生效。自 2015 年加入 Ingevity 以来，Platt 担任过多个关键财务领导职务，领导财务报告的改进，推动业务流程转型，并主导公司全球企业资源规划（ERP）系统的实施。他在全球财务运营的监督和推动技术驱动的流程改进方面的经验，使他能够很好地指导 Ingevity 的财务战略并支持公司的长期增长。</p>
<p><strong>性能化学品业务总裁过渡</strong></p>
<p>Rich White，高级副总裁兼性能化学品总裁，将于 2026 年 1 月 1 日起过渡到特别项目角色，并于 2026 年 5 月 1 日离开公司。White 于 2021 年被任命为性能化学品部门的总裁，自那时以来，他领导性能化学品经历了战略重组的阶段，包括利润率改善计划、产品组合优化和运营精简。</p>
<p>“我们感谢 Rich 对 Ingevity 的领导和贡献，” Li 表示。“在过去的几年中，他引导业务应对复杂的市场环境，并领导努力重组部门投资组合，以符合我们的战略优先事项。在他从当前角色过渡时，我们对他的指导表示感激，并相信他的专业知识将有助于确保连续性和稳定性。”</p>
<p><strong>新任高级副总裁的任命</strong></p>
<p>Ingevity 还宣布任命 Reid Clontz 为高级副总裁、运营及 Ingevity 执行领导团队成员，任职将于 2025 年 12 月 8 日生效。Clontz 最近担任 Ingevity 的全球运营副总裁，拥有超过二十年的化工行业经验，领导多个制造基地的运营，提高流程效率，并将生产与可持续发展目标对齐。他的领导在优化工厂运营和推动公司全球各地的持续改进方面发挥了重要作用。在新角色中，Clontz 还将负责公司的供应链、采购和安全职能。</p>
<p>“这些领导层的变动反映了我们致力于发展组织以支持长期战略优先事项，” Li 表示。“我们感谢 Mary 和 Rich 的重大贡献，并对 Reid 和 Phil 的新角色表示欢迎，确信他们深厚的运营和战略专业知识将帮助 Ingevity 继续实现增长和成功。”</p>
<p><strong>Ingevity：净化、保护、提升</strong></p>
<p>Ingevity 提供净化、保护和提升我们周围世界的产品和技术。通过一支才华横溢且经验丰富的团队，我们开发、制造并推向市场的解决方案，帮助客户解决复杂问题，使世界更加可持续。我们在三个报告部门运营：性能材料，包括活性炭；先进聚合物技术，包括己内酰胺聚合物；以及性能化学品，包括特种化学品和铺路技术。我们的产品用于多种苛刻应用，包括粘合剂、农用化学品、沥青铺路、认证可生物降解的生物塑料、涂料、弹性体、路面标记和汽车组件。Ingevity 总部位于南卡罗来纳州北查尔斯顿，在全球 24 个地点运营，雇佣约 1500 名员工。公司的普通股在纽约证券交易所（NYSE:NGVT）交易。欲了解更多信息，请访问 ingevity.com。</p>
<p><strong>前瞻性声明：</strong></p>
<p>本新闻稿包含根据 1934 年证券交易法（经修订）和 1995 年私人证券诉讼改革法的定义的 “前瞻性声明”。此类声明通常包括 “将”、“计划”、“打算”、“目标”、“期望”、“展望”、“相信”、“预期” 或类似的表达。前瞻性声明可能包括但不限于领导层变动；预期的财务状况、指导、经营结果和现金流；融资计划；以及商业策略和预期。实际结果可能与所表达的观点存在重大差异。导致实际结果与前瞻性声明中所包含的内容存在重大差异的因素，或可能导致其他前瞻性声明被证明不正确的因素，包括但不限于我们最近的 10-K 表格年度报告中第 I 部分第 1A 项 “风险因素” 中详细列出的因素，以及我们向 SEC 提交的其他文件。这些前瞻性声明仅反映管理层在本新闻稿发布日期的信念。Ingevity 不承担提供任何修订或更新本新闻稿中包含的任何预测和前瞻性声明的义务。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMDgxNDQzNTlyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMDgxNDQzNTlyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251208144359/en/</p>
<p>Caroline Monahan</p>
<p>843-740-2068</p>
<p>caroline.monahan@ingevity.com</p>
<p>投资者：</p>
<p>John E. Nypaver, Jr.</p>
<p>843-740-2002</p>
<p>investors@ingevity.com</p>
<p>来源：Ingevity Corporation</p>

NGVT

<p>Ingevity 公司宣布了关键的领导层变动，作为其战略投资组合审查的一部分。首席财务官 Mary Dean Hall 将在 2026 年 5 月卸任，由 Phillip J. Platt 接任。绩效化学品部门总裁 Rich White 将在 2026 年 5 月前转任特殊项目角色。Reid Clontz 被任命为运营高级副总裁，任命将于 2025 年 12 月生效。这些变动旨在支持 Ingevity 的长期战略优先事项和增长</p>

<p>NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future.</p>
<div class="lb-trans"><p>南卡罗来纳州北查尔斯顿 --（商业资讯）--Ingevity Corporation（纽约证券交易所代码：NGVT）今天宣布了关键的高管领导变动，以完成其战略投资组合审查并为公司的未来做好准备。</p>
</div><p><strong>Chief financial officer transition</strong></p>
<div class="lb-trans"><p><strong>首席财务官过渡</strong></p>
</div><p>Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity’s financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expansion, improved its capital structure and delivered strong free cash flow performance.</p>
<div class="lb-trans"><p>Mary Dean Hall，执行副总裁兼首席财务官（CFO），将于 2026 年 5 月 1 日起从当前职位过渡，并在接下来的一年内继续以顾问身份支持公司。自 2021 年以来，Hall 一直担任 CFO，在加强 Ingevity 的财务基础、提升运营纪律和支持战略增长计划方面发挥了关键作用。在她的财务领导下，公司实现了显著的利润率扩张，改善了资本结构，并交出了强劲的自由现金流表现。</p>
</div><p>“Mary has been a trusted advisor and a driving force behind our financial strategy,” said Dave Li, president and CEO. “Her deep expertise and steady guidance have been instrumental in positioning Ingevity for long-term success. We are grateful for her leadership and pleased she will continue to support the company during this transition.”</p>
<div class="lb-trans"><p>“Mary 一直是我们财务战略的可信顾问和推动力，” 首席执行官 Dave Li 表示。“她深厚的专业知识和稳定的指导对 Ingevity 的长期成功至关重要。我们感谢她的领导，并很高兴她在这一过渡期间继续支持公司。”</p>
</div><p>The company has appointed Phillip J. Platt, currently senior vice president, finance and chief accounting officer, as Hall’s successor and member of the executive leadership team, effective May 1, 2026. Since joining Ingevity in 2015, Platt has held key finance leadership roles where he led improvements in financial reporting, drove business process transformation and led implementation of the company’s global enterprise resource planning (ERP) system. His experience overseeing global finance operations and driving technology-enabled process improvements positions him well to guide Ingevity’s financial strategy and support the company’s long-term growth.</p>
<div class="lb-trans"><p>公司已任命 Phillip J. Platt，现任高级副总裁、财务和首席会计官，作为 Hall 的继任者，并成为执行领导团队的一员，任职将于 2026 年 5 月 1 日生效。自 2015 年加入 Ingevity 以来，Platt 担任过多个关键财务领导职务，领导财务报告的改进，推动业务流程转型，并主导公司全球企业资源规划（ERP）系统的实施。他在全球财务运营的监督和推动技术驱动的流程改进方面的经验，使他能够很好地指导 Ingevity 的财务战略并支持公司的长期增长。</p>
</div><p><strong>Performance Chemicals business president transition</strong></p>
<div class="lb-trans"><p><strong>性能化学品业务总裁过渡</strong></p>
</div><p>Rich White, senior vice president and president, Performance Chemicals, will transition to a special projects role, effective January 1, 2026, and will depart the company on May 1, 2026. White was named president of the Performance Chemicals segment in 2021 and has since led Performance Chemicals through a period of strategic repositioning, including margin improvement initiatives, product mix optimization and operational streamlining.</p>
<div class="lb-trans"><p>Rich White，高级副总裁兼性能化学品总裁，将于 2026 年 1 月 1 日起过渡到特别项目角色，并于 2026 年 5 月 1 日离开公司。White 于 2021 年被任命为性能化学品部门的总裁，自那时以来，他领导性能化学品经历了战略重组的阶段，包括利润率改善计划、产品组合优化和运营精简。</p>
</div><p>“We appreciate Rich’s leadership and contributions to Ingevity,” said Li. “Over the past several years, he has guided the business through complex market conditions and led efforts to restructure the segment portfolio in alignment with our strategic priorities. As he transitions from his current role, we are grateful for his guidance and know his expertise will help ensure continuity and stability.”</p>
<div class="lb-trans"><p>“我们感谢 Rich 对 Ingevity 的领导和贡献，” Li 表示。“在过去的几年中，他引导业务应对复杂的市场环境，并领导努力重组部门投资组合，以符合我们的战略优先事项。在他从当前角色过渡时，我们对他的指导表示感激，并相信他的专业知识将有助于确保连续性和稳定性。”</p>
</div><p><strong>New senior vice president of operations appointment</strong></p>
<div class="lb-trans"><p><strong>新任高级副总裁的任命</strong></p>
</div><p>Ingevity also announced the appointment of Reid Clontz to the role of senior vice president, operations and member of Ingevity’s executive leadership team, effective December 8, 2025. Clontz most recently served as vice president, global operations at Ingevity and brings more than two decades of chemical industry experience to his role, leading operations across multiple manufacturing sites, improving process efficiency and aligning production with sustainability goals. His leadership has been instrumental in optimizing plant operations and driving continuous improvement across the company’s global locations. In his new role, Clontz also assumes leadership for the company’s supply chain, procurement and safety functions.</p>
<div class="lb-trans"><p>Ingevity 还宣布任命 Reid Clontz 为高级副总裁、运营及 Ingevity 执行领导团队成员，任职将于 2025 年 12 月 8 日生效。Clontz 最近担任 Ingevity 的全球运营副总裁，拥有超过二十年的化工行业经验，领导多个制造基地的运营，提高流程效率，并将生产与可持续发展目标对齐。他的领导在优化工厂运营和推动公司全球各地的持续改进方面发挥了重要作用。在新角色中，Clontz 还将负责公司的供应链、采购和安全职能。</p>
</div><p>“These leadership transitions reflect our commitment to evolving our organization to support long-term strategic priorities,” said Li. “We thank Mary and Rich for their significant contributions and are excited to welcome Reid and Phil into their new roles, confident that their deep operational and strategic expertise will help position Ingevity for continued growth and success.”</p>
<div class="lb-trans"><p>“这些领导层的变动反映了我们致力于发展组织以支持长期战略优先事项，” Li 表示。“我们感谢 Mary 和 Rich 的重大贡献，并对 Reid 和 Phil 的新角色表示欢迎，确信他们深厚的运营和战略专业知识将帮助 Ingevity 继续实现增长和成功。”</p>
</div><p><strong>Ingevity: Purify, Protect, Enhance</strong></p>
<div class="lb-trans"><p><strong>Ingevity：净化、保护、提升</strong></p>
</div><p>Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and pavement technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components. Headquartered in North Charleston, South Carolina, Ingevity operates from 24 locations around the world and employs approximately 1,500 people. The company’s common stock is traded on the New York Stock Exchange (NYSE:NGVT). For more information, visit ingevity.com.</p>
<div class="lb-trans"><p>Ingevity 提供净化、保护和提升我们周围世界的产品和技术。通过一支才华横溢且经验丰富的团队，我们开发、制造并推向市场的解决方案，帮助客户解决复杂问题，使世界更加可持续。我们在三个报告部门运营：性能材料，包括活性炭；先进聚合物技术，包括己内酰胺聚合物；以及性能化学品，包括特种化学品和铺路技术。我们的产品用于多种苛刻应用，包括粘合剂、农用化学品、沥青铺路、认证可生物降解的生物塑料、涂料、弹性体、路面标记和汽车组件。Ingevity 总部位于南卡罗来纳州北查尔斯顿，在全球 24 个地点运营，雇佣约 1500 名员工。公司的普通股在纽约证券交易所（NYSE:NGVT）交易。欲了解更多信息，请访问 ingevity.com。</p>
</div><p><strong>Forward Looking Statement:</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明：</strong></p>
</div><p>This press release contains “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words “will,” “plans,” “intends,” “targets,” “expects,” “outlook,” “believes,” “anticipates” or similar expressions. Forward-looking statements may include, without limitation, leadership transitions; expected financial positions, guidance, results of operations and cash flows; financing plans; and business strategies and expectations. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, such factors detailed from time to time in Part I, Item 1A. Risk Factors in our most recent Annual Report on Form 10-K as well as in our other filings with the SEC. These forward-looking statements speak only to management’s beliefs as of the date of this press release. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.</p>
<div class="lb-trans"><p>本新闻稿包含根据 1934 年证券交易法（经修订）和 1995 年私人证券诉讼改革法的定义的 “前瞻性声明”。此类声明通常包括 “将”、“计划”、“打算”、“目标”、“期望”、“展望”、“相信”、“预期” 或类似的表达。前瞻性声明可能包括但不限于领导层变动；预期的财务状况、指导、经营结果和现金流；融资计划；以及商业策略和预期。实际结果可能与所表达的观点存在重大差异。导致实际结果与前瞻性声明中所包含的内容存在重大差异的因素，或可能导致其他前瞻性声明被证明不正确的因素，包括但不限于我们最近的 10-K 表格年度报告中第 I 部分第 1A 项 “风险因素” 中详细列出的因素，以及我们向 SEC 提交的其他文件。这些前瞻性声明仅反映管理层在本新闻稿发布日期的信念。Ingevity 不承担提供任何修订或更新本新闻稿中包含的任何预测和前瞻性声明的义务。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMDgxNDQzNTlyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20251208144359r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20251208144359/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251208144359/en/</p>
</div><p>Caroline Monahan</p>
<div class="lb-trans"><p>Caroline Monahan</p>
</div><p>843-740-2068</p>
<div class="lb-trans"><p>843-740-2068</p>
</div><p>caroline.monahan@ingevity.com</p>
<div class="lb-trans"><p>caroline.monahan@ingevity.com</p>
</div><p>Investors:</p>
<div class="lb-trans"><p>投资者：</p>
</div><p>John E. Nypaver, Jr.</p>
<div class="lb-trans"><p>John E. Nypaver, Jr.</p>
</div><p>843-740-2002</p>
<div class="lb-trans"><p>843-740-2002</p>
</div><p>investors@ingevity.com</p>
<div class="lb-trans"><p>investors@ingevity.com</p>
</div><p>Source: Ingevity Corporation</p>
<div class="lb-trans"><p>来源：Ingevity Corporation</p>
</div>

Ingevity 宣布重要的领导层变动 | NGVT 股票新闻